ESC Professional Premium Access

Comparative discontinuation and non-bleeding side effects of Clopidogrel, Prasugrel and Ticagrelor in patients with acute coronary syndromes; a Network Meta-analysis of Randomized Controlled Trials

Congress Presentation

About the speaker

Doctor Stav Yanko

Jerusalem (Israel)
0 follower

7 more presentations in this session

Anticoagulant monotherapy versus anticoagulant therapy in combination with single antiplatelet agent in patients after coronary artery bypass grafting - analysis of real-world data

Speaker: Associate Professor R. Dabrowski (Warsaw, PL)

Thumbnail

Impact of procedural and patient-related risks on 1-year outcomes for patients with 1-month DAPT followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation

Speaker: Doctor R. Shimada (Yahaba, JP)

Thumbnail

Clinical outcomes of risk score-guided dual antiplatelet therapy in patients with acute coronary syndrome who underwent percutaneous coronary intervention

Speaker: Assistant Professor D. Hyun (Kwang Ju, KR)

Thumbnail

The comparison of short-term dual antiplatelet therapy versus standard dual antiplatelet therapy in elderly patients with coronary artery disease who underwent percutaneous coronary intervention

Speaker: Doctor I. Jin (Seoul, KR)

Thumbnail

Elderly patients are hyperresponsive to potent P2Y12 inhibitors

Speaker: Doctor D. Mutschlechner (Mistelbach, AT)

Thumbnail

Access the full session

Data-driven decisions for anticoagulant and antiplatelet therapy

Speakers: Doctor S. Yanko, Associate Professor R. Dabrowski, Doctor R. Shimada, Assistant Professor D. Hyun, Doctor I. Jin...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations